Unknown

Dataset Information

0

Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications.


ABSTRACT: The goal of cancer immunotherapy is to establish new or boost pre-existing anticancer immune responses that eradicate malignant cells while generating immunological memory to prevent disease relapse. Over the past few years, immunomodulatory monoclonal antibodies (mAbs) that block co-inhibitory receptors on immune effectors cells - such as cytotoxic T lymphocyte-associated protein 4 (CTLA4), programmed cell death 1 (PDCD1, best known as PD-1) - or their ligands - such as CD274 (best known as PD-L1) - have proven very successful in this sense. As a consequence, many of such immune checkpoint blockers (ICBs) have already entered the clinical practice for various oncological indications. Considerable attention is currently being attracted by a second group of immunomodulatory mAbs, which are conceived to activate co-stimulatory receptors on immune effector cells. Here, we discuss the mechanisms of action of these immunostimulatory mAbs and summarize recent progress in their preclinical and clinical development.

SUBMITTER: Cabo M 

PROVIDER: S-EPMC5706611 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications.

Cabo Mariona M   Offringa Rienk R   Zitvogel Laurence L   Kroemer Guido G   Muntasell Aura A   Galluzzi Lorenzo L  

Oncoimmunology 20170830 12


The goal of cancer immunotherapy is to establish new or boost pre-existing anticancer immune responses that eradicate malignant cells while generating immunological memory to prevent disease relapse. Over the past few years, immunomodulatory monoclonal antibodies (mAbs) that block co-inhibitory receptors on immune effectors cells - such as cytotoxic T lymphocyte-associated protein 4 (CTLA4), programmed cell death 1 (PDCD1, best known as PD-1) - or their ligands - such as CD274 (best known as PD-  ...[more]

Similar Datasets

| S-EPMC4485728 | biostudies-literature
| S-EPMC4368132 | biostudies-literature
| S-EPMC3961485 | biostudies-literature
| S-EPMC4292758 | biostudies-literature
| S-EPMC4590013 | biostudies-literature
| S-EPMC5706602 | biostudies-literature
| S-EPMC4091055 | biostudies-literature
| S-EPMC5048768 | biostudies-literature
| S-EPMC7466852 | biostudies-literature
| S-EPMC3583934 | biostudies-literature